Thanks to biotechnology applications such as PCR tests and mRNA vaccines, Europe saw a way out of the COVID-19 pandemic. What comes next is exploring the full potential of life science in the healthcare sector.
The EU's Orphan Regulation was introduced in 2000 and its main objective was to address the challenge of regulating medicines which treat an estimated 30 million patients with rare diseases across the EU.
Download PDF
The Orphan Regulation was introduced in 2000 and its main objective was to address the challenge of regulating medicines which treat patients with rare diseases. Around 246,000 people suffer from such diseases across the EU, The European Commission is expected to present …
